Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

The combination of EDSS scores above 6 and age over 55 years resulted in higher serious infection rate that was nearly double that seen in the overall population.

Long-Term Data of Ocrelizumab Highlights Specific Patient Population at Risk for Severe Infection

In mixed-effect analyses adjusting for multiple cofounders, changes in inflammatory gene expression correlated inversely with changes in patient-reported stress, loneliness, hair cortisol, and aspects of interoceptive awareness.

Mindfulness-Based Stress Reduction Intervention Shows Potential to Treat Silent Symptoms of Multiple Sclerosis

In July, the FDA is expected to make a decision on lecanemab (Leqembi), an antiamyloid therapy previously approved under the accelerated approval pathway, for a potential traditional approval for early-stage Alzheimer disease.

CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease

Investigators observed significant correlations between processing speed and arterial stiffness among patients with multiple sclerosis, but not in healthy controls. 

Arterial Stiffness Associated With Processing Speed in Multiple Sclerosis

, has been with the team since October 2019. Follow him on Twitter 

Despite similar proportion of females and ever-smokers, age of onset of multiple sclerosis was significantly earlier for Latinx patients compared with White non-Latinx individuals.

Multiple Sclerosis Onset Begins Significantly Earlier in Latinx Patients

Cornelia Drees, MD, senior associate consultant, Department of Neurology, Mayo Clinic, discussed the potential of microburst vagus nerve stimulation as a more targeted treatment for drug-resistant epilepsy. 

NeuroVoices: Cornelia Drees, MD, on Understanding the Different Advantages of Microburst Vagus Nerve Stimulation

Tiffany Braley, MD, MS, associate professor of neurology, University of Michigan, provided insight on the challenges of fatigue in multiple sclerosis, and where research efforts should be directed to.

World MS Day: Improving Fatigue in Multiple Sclerosis

, has been with the team since September 2022. Follow her on Twitter 

In recognition of World MS Day, Meghan Beier, PhD, MA, a health and rehabilitation psychologist at the Rowan Center for Behavioral Medicine, discussed the effects of multiple sclerosis (MS) on cognitive function. 

World MS Day: Cognitive Function in Multiple Sclerosis

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

Ataxia

CMSC 2023

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Slideshows

Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.

Clinical

BIO-22-NRD0187 - /clinical/headache-migraine

Migraine: Leading Cause of Improper t-PA Use

Migraine: Leading Cause of Improper t-PA Use

FDA Accepts NDA for DHE Nasal Powder Product STS101 for Acute Migraine

Episode 88: 2023 AAN Annual Meeting Highlights

NeurologyLive® Brain Games: May 28, 2023

Episode 67: Mental Health and Advocacy in Pediatric Migraine

Research Suggests Connection Between Sex Hormones and CGRP in Migraine Pathophysiology

This Week on NeurologyLive® — May 22, 2023

FDA Accepts NDA for DHE Nasal Powder Product STS101 for Acute Migraine

Episode 88: 2023 AAN Annual Meeting Highlights

NeurologyLive® Brain Games: May 28, 2023

Episode 67: Mental Health and Advocacy in Pediatric Migraine

Research Suggests Connection Between Sex Hormones and CGRP in Migraine Pathophysiology

This Week on NeurologyLive® — May 22, 2023

FDA Accepts NDA for DHE Nasal Powder Product STS101 for Acute Migraine

Episode 88: 2023 AAN Annual Meeting Highlights

NeurologyLive® Brain Games: May 28, 2023

Episode 67: Mental Health and Advocacy in Pediatric Migraine

Research Suggests Connection Between Sex Hormones and CGRP in Migraine Pathophysiology

This Week on NeurologyLive® — May 22, 2023